Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
12.06
-0.49 (-3.90%)
Feb 4, 2026, 2:52 PM EST - Market open
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $1.62 billion as of February 4, 2026. Its market cap has increased by 430.54% in one year.
Market Cap
1.62B
Enterprise Value
1.57B
1-Year Change
430.54%
Ranking
Category
Stock Price
$12.06
Market Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $1.62B, an increase of 939.12%. That is a compound annual growth rate of 62.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.69B | 41.65% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | 156.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.75B |
| uniQure | 1.73B |
| Nurix Therapeutics | 1.73B |
| Precigen | 1.70B |
| Celldex Therapeutics | 1.67B |
| Upstream Bio | 1.67B |
| Oruka Therapeutics | 1.67B |
| Tyra Biosciences | 1.67B |